The Al Haouz earthquake, named after the Moroccan province most...
Category:
Disaster & Management
Latest
Irdai chief stresses spreading of natural calamity covers in high-risk regions
Debasish Panda, Chairman,Irdai, is addressing an international...
Auto cos unveil comprehensive service plan to serve flood-affected customers
"The cyclone Michaung has had a severe impact on the lives and...
Indian pharma majors race ahead to launch affordable drugs for Covid-19 treatment
Drug major Cipla is working with government agencies to develop a treatment for COVID-19 while ramping up the production of various life saving essential drugs, according to company’s chairman YK Hamied.
Drug firm BDR Pharmaceuticals on Wednesday said it has launched its antiviral drug Favipiravir for the treatment of COVID-19 patients in India at a price of Rs 63 per tablet.
Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name ‘Covihalt’ for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.
Global coronavirus deaths exceed 700,000, one person dies every 15 seconds on average
Even in parts of the world that had appeared to have curbed the spread of the virus, countries have recently seen single-day records in new cases, signaling the battle is far from over. Australia, Japan, Hong Kong, Bolivia, Sudan, Ethiopia, Bulgaria, Belgium, Uzbekistan and Israel all recently had record increases in cases.
Proportion of youth with COVID-19 triples in five months: WHO
An analysis by the WHO of 6 million infections between Feb. 24 and July 12 found that the share of people aged 15-24 years rose to 15% from 4.5%.
Apart from the United States which leads a global tally with 4.8 million total cases, European countries including Spain, Germany and France, and Asian countries such as Japan, have said that many of the newly infected are young people.
“Younger people tend to be less vigilant about masking and social distancing,” Neysa Ernst, nurse manager at Johns Hopkins Hospital’s biocontainment unit in Baltimore, Maryland told Reuters in an email.
How the pandemic may change ‘work-life balance’ forever
Some of the best companies for work-life balance] have really great paid-time off policies, flexible working schedules, good parental leave, sabbaticals and gym credits,” said Amanda Stansell, senior research analyst at workplace website Glassdoor. But as workers shifted to remote work, the spirit of in-person events and company culture needed to be recreated at home
Are pharma companies are trying to profiteer from Covid-19 vaccines
If a vaccine proves too expensive or difficult to obtain, those who seek exorbitant profits off of it will be scrutinized far more closely than bankers were after the 2008 crash. Actions like those that have already allowed insiders to pocket $80 million will provoke public revulsion, even if those trades were pre-scheduled. Calls to regulate sectors that take for granted intellectual property protections will grow exponentially. Those demands won’t be fanatical or radical, but mainstream.
India ‘flying blind’, needs better data collection to control Covid-19
India’s death registration data was patchy even before the virus struck. The vast majority of deaths, especially in rural villages, take place at home and routinely go unregistered. For others the cause of death listed is often anodyne — old age or heart attack. Experts believe that only between 20 per cent-30 per cent of all deaths in India are properly medically certified.
WHO says China team interviewed Wuhan scientists over virus origins
The results of the WHO investigation are keenly awaited by scientists and governments around the world, none more so than Washington, which lobbied hard for the mission. The
“The team had extensive discussions with Chinese counterparts and received updates on epidemiological studies, biologic and genetic analysis and animal health research,” Christian Lindmeier told reporters, saying these included video discussions with Wuhan virologists and scientists.
Trump administration accuses the WHO of being China-centric and plans to leave the agency over its handling of the pandemic.
COVID-19 spread reported in new areas but 82% of total cases from 10 states/UTs: Health ministry
Giving a break-up of the mortality rate according to gender, Union health secretary Rajesh Bhushan said about 68 per cent of COVID-19 deaths were reported among male patients and 32 per cent among female patients in India
India may see the most Covid 19 cases in the world
It’s looking increasingly likely that India will wind up being the country with the most cases in the world. This is not just a function of its massive population; China, too, has over 1 billion people. It is a reflection of the fact that big, diverse countries are at a disadvantage in dealing with pandemics
Anxious WHO implores world to ‘do it all’ in long war on COVID-19
WHO Director-General Tedros Adhanom Ghebreyesus and WHO emergencies head Mike Ryan exhorted nations to rigorously enforce health measures such as mask-wearing, social distancing, hand-washing and testing.
“There are concerns that we may not have a vaccine that may work, or its protection could be for just a few months, not more. But until we finish the clinical trials, we will not know,” he said